Michelle P. Luo

Health‐related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: Results from a randomized controlled study

John C. Davis, Dennis A. Revicki, Désirée M. F. van der Heijde et al. · Arthritis Care & Research · 2007 · 90 citations

Pharmacy, Internal Medicine, Pharmacotherapy +12

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).

Dennis A. Revicki, Michelle P. Luo, P Wordsworth et al. · PubMed · 2008 · 75 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Imbalanced Expression of Inhibin and Activin Subunits in Primary Epithelial Ovarian Cancer

Wenxin Zheng, Michelle P. Luo, Corrine K. Welt et al. · Gynecologic Oncology · 1998 · 70 citations

Medicine, Cancer Biology, Oncology +16

Cost-Effectiveness of Lopinavir/Ritonavir Versus Nelfinavir As the First-Line Highly Active Antiretroviral Therapy Regimen for HIV Infection

Kit N. Simpson, Michelle P. Luo, Elinor C. Chumney et al. · HIV Clinical Trials · 2004 · 66 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire

Lynda Doward, Stephen P. McKenna, David Meads et al. · Health and Quality of Life Outcomes · 2007 · 58 citations · Full text

Pharmacy, Internal Medicine, Health Assessment +16